Drugs / H053
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05113693 | Nov → Dec 2021 | type 2 diabetes mellitus | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
| Phase 1 | NCT04768673 | Mar → Apr 2021 | type 2 diabetes mellitus | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H053 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05113693 ↗ |
| Route | Oral | “single, oral administration of 1 D501, 1 D759 and 2 H053 under fed condition” NCT04768673 ↗ |